InMode Investor Relations Material

InMode is a medical technology company that specializes in developing innovative solutions for minimally invasive cosmetic and medical procedures. The company was founded in 2008 and has since become a leading provider of minimally invasive aesthetic and medical treatments. Some of InMode’s competitors include Cutera, LivaNova, and TransMedics.

InMode's business model is based on developing and marketing cutting-edge medical technology solutions to meet the specific needs of physicians and patients around the world. The company's products and services include minimally invasive treatments for body contouring, skin rejuvenation, women's health, and more.

InMode generates revenue primarily through the sale of its medical technology products, as well as through ongoing customer support and service contracts. The company's revenue is also generated through its partnerships with other healthcare companies and organizations, as well as through collaborations with academic research institutions and other organizations.

InMode has developed and patented a range of advanced technologies that have revolutionized the field of medical aesthetics. One such technology is its BodyTite system, which uses radiofrequency energy to deliver heat to targeted areas of the body, tightening the skin and reducing fat without the need for surgery. The company has also developed minimally invasive treatments for vaginal rejuvenation, hair removal, and tattoo removal, among others.